Eli Lilly Ceo Our Pill

May 30, 2026
Media Summary: The increasing popularity of GLP-1 weight-loss drugs has driven drugmaker

Eli Lilly Ceo Our Pill - Detailed Analysis & Overview

The increasing popularity of GLP-1 weight-loss drugs has driven drugmaker

Photo Gallery

Eli Lilly CEO: Our pill supply can 'reach the planet'
Eli Lilly Is Working on an Anti-Obesity Pill, Says CEO Dave Ricks
Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine
Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing
Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma
Eli Lilly CEO on weight loss drugs outlook: Our top priority is making more product
Eli Lilly CEO David Ricks on $1T market value, obesity pill launch and drug pipeline outlook
Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
Eli Lilly CEO: We see a path to an Alzheimer's disease-modifying drug
Eli Lilly CEO David Ricks on Q3 results: The underlying growth story is fantastic
Eli Lilly CEO David Ricks on Q1 results, weight loss drug competition and status of weight-loss pill
Eli Lilly CEO talks deal to cut medication prices with the Trump administration

Related Plants

Eli Lilly CEO: Our pill supply can 'reach the planet' Eli Lilly Is Working on an Anti-Obesity Pill, Says CEO Dave Ricks Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma Eli Lilly CEO on weight loss drugs outlook: Our top priority is making more product Eli Lilly CEO David Ricks on $1T market value, obesity pill launch and drug pipeline outlook Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing The Dark Side Of Honeysuckle: Uncovering Its Hidden Dangers In Your Garden Beyond The Cutting Board: Uncovering The Unlikely Future Of Cleavers In Modern Medicine The Dark Side Of Hydrangea Care You Never Knew The Dark Side Of Imfile: What You Don't Know Could Cost You Thousands The Lost Art Of Authentic Acadia Jade Carvings: Expert Insights Inside The Hidden Rsyslog Risk That's Silently Compromising Your Security Revealed: How Japanese Painted Ferns Can Transform Your Home Decor In One Simple Step Bentonite Clay Face Masks Can Help You Detox Without Harsh Chemicals
View Detailed Profile
Eli Lilly CEO: Our pill supply can 'reach the planet'

Eli Lilly CEO: Our pill supply can 'reach the planet'

Eli Lilly

Eli Lilly Is Working on an Anti-Obesity Pill, Says CEO Dave Ricks

Eli Lilly Is Working on an Anti-Obesity Pill, Says CEO Dave Ricks

Eli Lilly

Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine

Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine

The increasing popularity of GLP-1 weight-loss drugs has driven drugmaker

Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing

Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing

Eli Lilly

Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma

Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma

Dave Ricks, the

Eli Lilly CEO on weight loss drugs outlook: Our top priority is making more product

Eli Lilly CEO on weight loss drugs outlook: Our top priority is making more product

Eli Lilly CEO

Eli Lilly CEO David Ricks on $1T market value, obesity pill launch and drug pipeline outlook

Eli Lilly CEO David Ricks on $1T market value, obesity pill launch and drug pipeline outlook

Eli Lilly

Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

(0:00) Introducing

Eli Lilly CEO: We see a path to an Alzheimer's disease-modifying drug

Eli Lilly CEO: We see a path to an Alzheimer's disease-modifying drug

Eli Lilly CEO

Eli Lilly CEO David Ricks on Q3 results: The underlying growth story is fantastic

Eli Lilly CEO David Ricks on Q3 results: The underlying growth story is fantastic

Eli Lilly CEO

Eli Lilly CEO David Ricks on Q1 results, weight loss drug competition and status of weight-loss pill

Eli Lilly CEO David Ricks on Q1 results, weight loss drug competition and status of weight-loss pill

Eli Lilly

Eli Lilly CEO talks deal to cut medication prices with the Trump administration

Eli Lilly CEO talks deal to cut medication prices with the Trump administration

NBC News' Tom Llamas talks to

Eli Lilly CEO on Fighting Obesity, Developing New Drugs

Eli Lilly CEO on Fighting Obesity, Developing New Drugs

Eli Lilly